- Home
- ANVS vs ETON Comparison
ANVS vs ETON Comparison
Compare ANVS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- ETON
- Stock Information
- Founded
- ANVS 2008
- ETON 2017
- Country
- ANVS United States
- ETON United States
- Employees
- ANVS N/A
- ETON N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- ANVS Health Care
- ETON Health Care
- Exchange
- ANVS Nasdaq
- ETON Nasdaq
- Market Cap
- ANVS 110.4M
- ETON 199.5M
- IPO Year
- ANVS 2020
- ETON 2018
- Fundamental
- Price
- ANVS $9.57
- ETON $8.82
- Analyst Decision
- ANVS Strong Buy
- ETON Strong Buy
- Analyst Count
- ANVS 6
- ETON 3
- Target Price
- ANVS $29.67
- ETON $12.00
- AVG Volume (30 Days)
- ANVS 341.4K
- ETON 214.1K
- Earning Date
- ANVS 11-06-2024
- ETON 11-11-2024
- Dividend Yield
- ANVS N/A
- ETON N/A
- EPS Growth
- ANVS N/A
- ETON N/A
- EPS
- ANVS N/A
- ETON N/A
- Revenue
- ANVS N/A
- ETON $31,381,000.00
- Revenue This Year
- ANVS N/A
- ETON $19.61
- Revenue Next Year
- ANVS N/A
- ETON $35.39
- P/E Ratio
- ANVS N/A
- ETON N/A
- Revenue Growth
- ANVS N/A
- ETON 8.14
- 52 Week Low
- ANVS $4.53
- ETON $3.03
- 52 Week High
- ANVS $22.49
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- ANVS 58.70
- ETON 76.07
- Support Level
- ANVS $9.00
- ETON $7.58
- Resistance Level
- ANVS $10.54
- ETON $8.66
- Average True Range (ATR)
- ANVS 0.81
- ETON 0.42
- MACD
- ANVS 0.12
- ETON -0.07
- Stochastic Oscillator
- ANVS 74.57
- ETON 91.49
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.